Mercer Global Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Sell
168,903
-2,145
-1% -$148K 0.02% 330
2025
Q1
$11.9M Sell
171,048
-22,970
-12% -$1.59M 0.03% 327
2024
Q4
$16.7M Sell
194,018
-27,011
-12% -$2.32M 0.04% 249
2024
Q3
$26.1M Buy
221,029
+16,448
+8% +$1.94M 0.06% 171
2024
Q2
$29.2M Buy
204,581
+8,030
+4% +$1.15M 0.08% 149
2024
Q1
$25.5M Sell
196,551
-6,255
-3% -$813K 0.07% 164
2023
Q4
$21M Buy
202,806
+12,430
+7% +$1.29M 0.06% 187
2023
Q3
$17.3M Buy
190,376
+2,052
+1% +$187K 0.07% 186
2023
Q2
$15.2M Buy
188,324
+19,014
+11% +$1.54M 0.06% 207
2023
Q1
$13.5M Sell
169,310
-4,356
-3% -$347K 0.06% 223
2022
Q4
$11.8M Sell
173,666
-20,954
-11% -$1.42M 0.06% 241
2022
Q3
$9.7M Sell
194,620
-3,830
-2% -$191K 0.06% 231
2022
Q2
$11.1M Buy
198,450
+18,960
+11% +$1.06M 0.07% 207
2022
Q1
$9.97M Sell
179,490
-22,926
-11% -$1.27M 0.06% 229
2021
Q4
$11.3M Buy
202,416
+4,674
+2% +$262K 0.07% 203
2021
Q3
$9.49M Buy
197,742
+19,928
+11% +$957K 0.07% 237
2021
Q2
$7.45M Buy
177,814
+7,460
+4% +$312K 0.06% 258
2021
Q1
$5.74M Buy
170,354
+2,264
+1% +$76.3K 0.05% 274
2020
Q4
$5.87M Buy
168,090
+4,262
+3% +$149K 0.07% 204
2020
Q3
$5.69M Buy
163,828
+47,068
+40% +$1.63M 0.09% 179
2020
Q2
$3.82M Buy
116,760
+30,836
+36% +$1.01M 0.07% 203
2020
Q1
$2.59M Buy
85,924
+33,298
+63% +$1M 0.06% 265
2019
Q4
$1.52M Buy
52,626
+870
+2% +$25.2K 0.03% 407
2019
Q3
$1.34M Buy
51,756
+6,806
+15% +$176K 0.03% 403
2019
Q2
$1.15M Buy
44,950
+2,394
+6% +$61.1K 0.03% 426
2019
Q1
$1.11M Buy
+42,556
New +$1.11M 0.04% 386